本页面由Tiger Trade Technology Pte. Ltd.提供服务

Xtl生物制药

2.71
-0.0700-2.52%
成交量:822
成交额:2,232.51
市值:665.98万
市盈率:-0.87
高:2.71
开:2.71
低:2.71
收:2.78
52周最高:10.28
52周最低:2.01
股本:245.75万
流通股本:138.37万
量比:0.23
换手率:0.06%
股息:- -
股息率:- -
每股收益(TTM):-3.1316
每股收益(LYR):-5.9716
净资产收益率:-29.30%
总资产收益率:-21.01%
市净率:-26.22
市盈率(LYR):-0.45

数据加载中...

2026/06/30

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/05/01

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/04/30

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/03/22

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/03/30

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/05/19

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/15

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/11/25

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/12

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/01/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/22

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/13

非美公司披露报告

[Amend] Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]